Hormone Tx Tied to Reductions in Insulin Resistance
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 11, 2024 -- Hormone therapy (HT) is associated with significantly reduced insulin resistance in healthy postmenopausal women, according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.
Tanya Li, from Reading Hospital Tower Health in West Reading, Pennsylvania, and colleagues conducted a systematic literature review to identify randomized controlled trials (1998 to 2024) that evaluated the effect of HT on insulin resistance, measured by the homeostasis model assessment of insulin resistance (HOMA-IR), in postmenopausal women without diabetes, hypertension, or cardiovascular diseases.
Based on pooled data from 17 included trials (29,287 postmenopausal women), the researchers found the HOMA-IR was significantly reduced in women who received HT (overall effect: raw mean difference [RMD], −0.24; P < 0.001; I2 = 60.3 percent) compared with those who received placebo. The HOMA-IR was significantly reduced in both women who received estrogen alone (RMD = −0.42; P < 0.001) and those who received estrogen plus progestogen (RMD = −0.14; P = 0.005) versus those who received placebo.
“Our analysis showed that both types of hormone therapy, including oral and transdermal routes, significantly reduced insulin resistance in healthy postmenopausal women, although estrogen alone was associated with a more prominent reduction when compared to a combination hormone therapy," lead researcher Xuezhi Jiang, M.D., also from Reading Hospital Tower Health, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-12 05:30
Read more
- Can Cannabis Change Your Brain? Maybe, Maybe Not
- Stereotactic Radiosurgery Safe for Koos Grade I Vestibular Schwannomas
- Adequate Sleep Linked to Reduced Risk for Hypertension in Teens
- Nearly 160 Million Americans Harmed by Another's Drinking, Drug Use
- Nasal Swab Might Predict How Severe COVID Will Be
- More Evidence That GLP-1 Meds Curb Alcohol Abuse
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions